Undersøgelsen omfattede 571 voksne, der var "behandlingsnaive" (dvs. ikke tidligere behandlet for hiv- infektion).
The first study compared Emtriva with stavudine (another antiviral medicine) in 571 treatment-naïve adults (who had not received treatment for their HIV infection before).